李红梅

• 1:河南周口市中心医院

摘要(Abstract)：

关键词(KeyWords)： 盐酸美金刚;阿尔茨海默病;早老性痴呆;原发性痴呆

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 李红梅

参考文献(References)：

• [1]李楠,王建平,李建章.褪黑素用于阿尔茨海默病治疗的机制[J].中国实用神经疾病杂志,2006,9(2):49-50.
• [2]Wilcock CK.Memantine for the heatnt of dementia[J].Lan-cet Neurol,2003,2(8):503-505.
• [3]Kilpatrick GJ,Tilbbok CS.Memantine[J].Metz Gutt Opin In-vestig Drugs,2002,3(5):798-806.
• [4]Rogawsk MA,Wenk CL.The neuropharmacological husis forthe use of memantion in the treatment of Alzheimer’s disease[J].CNS Drug Ree,2003,9(3):275-308.
• [5]Jain KK.Erahuation of memantine for neuroptotertion in de-mentis[J].Exppert Opin Inreslig Drugs,2000,9(6):1397-1406.
• [6]Doraiswamy PM.Alsheimers disease and the glutamatin NM-DA rceptor[J].Prychopharmacol Bull,2003,37(2):41-49.
• [7]Cacabelos R.Pharmacogenomics and therapeutic prospects inAlzheiner’s disease[J].Expert Opin Pharmacother,2005,6(12):1967-1987.
• [8]Periclou AP,Ventura D,Sherman T,et al.Lack of pharma-cokinctic or pltarmacodynamic interaction between memantineand donepezil[J].Int J Ceriatr Psychiatry,2004,19(10):919-925.
• [9]Tariot PN,Farlow MR,Grossberg CT.Memantine treatmentin patients with moderate to severe Alzheimer disease alreadyreceiving donepezil:a randomized controlled trial[J].JAMA,2004,291(3):317-324.
• [10]Gaufhier S,Virth Mobius HJ.Effects of mentantine or borsinptonts in Alzheimer’s disease patients:an appraise of thenemropsychiatrin invenlory(NPI)data of two randomized,contrulted studies[J].Iut J Geriatr Psychiatry,2005,20(5):459-464.
• [11]Reisderc B,Ferris S,Mobius HJ,et al.Long-term treatmentwith the NMDA entaganis memantine:results of a 24 week,open-labet exteosion study in moderately sevcre-to-scvereAlzheimer’s disehse[J].Neurobiat Aging,2002,23(1):5555.
• [12]Sonkusare SK,Kaui CL,Ramarao P.Dementis of Alzhei-mer’s disease and other ncurodegeneraive disorders-rue-man-tine,a new hope[J].Pharmacol Res,2005,51(1):1-17.
• [13]Plosker CL,Lyseng-Willjamson KA.Menantine:A pharma-coceontinc revtew of its use in moderate-to-severe Alzheimer’sDisease[J].Pharmacoeconomics,2005,23(2):193-206.